Animal models of serotonergic psychedelics

ACS Chemical Neuroscience

Volumn 4, Issue 1, 2013, Pages 33-42

  Hanks, James B ^a   González Maeso, Javier ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

G protein coupled receptor (GPCR); hallucinogenic; lysergic acid diethylamide (LSD); mouse behavior models; Psychedelic; psychosis; schizophrenia; serotonin 5 HT 2A receptor

Indexed keywords

2,5 DIMETHOXY 4 METHYLAMPHETAMINE; 4 AMINOBUTYRIC ACID RECEPTOR; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 4,5,7A,8,9,10,11,11A OCTAHYDRO 10 METHYL 7H INDOLO[1,7 BC][2,6]NAPHTHYRIDINE; 8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; AMPHETAMINE; BROLAMFETAMINE; CANNABINOID 1 RECEPTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR; DIZOCILPINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; KETAMINE; LYSERGIDE; MESCALINE; METABOTROPIC RECEPTOR 2; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PSILOCYBINE; PSYCHEDELIC AGENT; SALVINORIN A; SEROTONIN 1A RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN AGONIST; TETRAHYDROCANNABINOL; VOLINANSERIN;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANXIETY; BRAIN REGION; CONDITIONING; CONFLICT; DRUG DISCRIMINATION; EXPERIMENTAL MODEL; EXPLORATORY BEHAVIOR; FEAR; HEAD TWITCH; HUMAN; IMPULSIVENESS; LOCOMOTION; MEMORY; MOLECULAR DYNAMICS; NEUROPSYCHOLOGY; NONHUMAN; OPEN FIELD TEST; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSIS; REINFORCEMENT; REVIEW; SCHIZOPHRENIA; STARTLE REFLEX; STIMULUS RESPONSE; TASK PERFORMANCE; TIME PERCEPTION; VOCALIZATION;

ANIMALS; ANXIETY; DISCRIMINATION (PSYCHOLOGY); EXPLORATORY BEHAVIOR; HALLUCINOGENS; HEAD MOVEMENTS; HUMANS; IMPULSIVE BEHAVIOR; MEMORY; MICE; MODELS, ANIMAL; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, G-PROTEIN-COUPLED; REINFORCEMENT SCHEDULE; RODENTIA; SEROTONIN 5-HT2 RECEPTOR AGONISTS; STARTLE REACTION; TIME PERCEPTION;

ANIMALIA; RODENTIA;

EID: 84872524508     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn300138m     Document Type: Review

References (149)

1. Hofmann, A. (1980) LSD: My Problem Child, McGraw-Hill, New York.
2. Shulgin, A. S. A. (1995) PIHKAL: Phenethylamines I have known and loved: a chemical love story, Transform Press, Berkeley.
3. Griffiths, R. R., Richards, W. A., McCann, U., and Jesse, R. (2006) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology 187, 268-283 discussion 284-292 (Pubitemid 44088380)
4. Gouzoulis-Mayfrank, E., Heekeren, K., Neukirch, a., Stoll, M., Stock, C., Obradovic, M., and Kovar, K.-a. (2005) Psychological effects of (S)-ketamine and N, N -dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers Pharmacopsychiatry 38, 301-311 (Pubitemid 41815687)
5. Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F., Babler, A., Vogel, H., and Hell, D. (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action NeuroReport 9, 3897-3902 (Pubitemid 29189323)
6. Osmond, H. (1957) A review of the clinical effects of psychotomimetic agents Ann. N.Y. Acad. Sci. 66, 418-434
7. Nichols, D. E. (2004) Hallucinogens Pharmacol Ther. 101, 131-81 (Pubitemid 38167565)
8. Gonzalez-Maeso, J. and Sealfon, S. C. (2009) Agonist-trafficking and hallucinogens Curr. Med. Chem. 16, 1017-1027
9. Morris, B. J., Cochran, S. M., and Pratt, J. A. (2005) PCP: from pharmacology to modelling schizophrenia Curr. Opin. Pharmacol. 5, 101-106 (Pubitemid 40124542)
10. Kristiansen, L. V., Huerta, I., Beneyto, M., and Meador-Woodruff, J. H. (2007) NMDA receptors and schizophrenia Curr. Opin. Pharmacol. 7, 48-55
11. Halpern, J. H. (2004) Hallucinogens and dissociative agents naturally growing in the United States Pharmacol. Ther. 102, 131-138 (Pubitemid 38681012)
12. Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., and Rothman, R. B. (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist Proc. Natl. Acad. Sci. U.S.A. 99, 11934-11939 (Pubitemid 34994502)
13. Strassman, R. J., Qualls, C. R., Uhlenhuth, E. H., and Kellner, R. (1994) Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale Arch. Gen. Psychiatry 51, 98-108 (Pubitemid 24054311)
14. Studerus, E., Gamma, A., Kometer, M., and Vollenweider, F. X. (2012) Prediction of psilocybin response in healthy volunteers PloS One 7, e30800
15. Studerus, E., Gamma, A., and Vollenweider, F. X. (2010) Psychometric evaluation of the altered states of consciousness rating scale (OAV) PloS One 5, e12412
16. Weinstein, H. (2005) Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors AAPS J. 7, E871-884
17. Nichols, D. E. and Nichols, C. D. (2008) Serotonin receptors Chem. Rev. 108, 1614-1641 (Pubitemid 351796401)
18. Aghajanian, G. K. (2009) Modeling ″psychosis″ in vitro by inducing disordered neuronal network activity in cortical brain slices Psychopharmacology (Berlin, Ger.) 206, 575-585
19. Appel, J. B., West, W. B., and Buggy, J. (2004) LSD, 5-HT (serotonin), and the evolution of a behavioral assay Neurosci. Biobehav. Rev. 27, 693-701 (Pubitemid 38199602)
20. Fantegrossi, W. E., Murnane, K. S., and Reissig, C. J. (2008) The behavioral pharmacology of hallucinogens Biochem. Pharmacol. 75, 17-33 (Pubitemid 350235393)
21. Nesse, R. M. and Berridge, K. C. (1997) Psychoactive drug use in evolutionary perspective Science 278, 63-66 (Pubitemid 27446272)
22. Vollenweider, F. X. and Kometer, M. (2010) The neurobiology of psychedelic drugs: implications for the treatment of mood disorders Nat. Rev. Neurosci. 11, 642-651
23. Gonzalez-Maeso, J. and Sealfon, S. C. (2009) Psychedelics and schizophrenia Trends Neurosci. 32, 225-232
24. Geyer, M. A. and Vollenweider, F. X. (2008) Serotonin research: contributions to understanding psychoses Trends Pharmacol. Sci. 29, 445-453
25. Dittrich, A. (1998) The standardized psychometric assessment of altered states of consciousness (ASCs) in humans Pharmacopsychiatry 31 (Suppl 2) 80-84 (Pubitemid 28396276)
26. Crawley, J. N. (2007) What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice, 2 nd ed., Wiley, John & Sons.
27. Gonzalez-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., Sealfon, S. C., and Gingrich, J. A. (2007) Hallucinogens Recruit Specific Cortical 5-HT(2A) Receptor-Mediated Signaling Pathways to Affect Behavior Neuron 53, 439-452 (Pubitemid 46161267)
28. Gonzalez-Maeso, J., Yuen, T., Ebersole, B. J., Wurmbach, E., Lira, A., Zhou, M., Weisstaub, N., Hen, R., Gingrich, J. A., and Sealfon, S. C. (2003) Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex J. Neurosci. 23, 8836-8843 (Pubitemid 37210895)
29. Martin, W. R., Wikler, A., Eades, C. G., and Pescor, F. T. (1963) Tolerance to and Physical Dependence on Morphine in Rats Psychopharmacologia 4, 247-260
30. Woolley, D. W. (1955) Production of Abnormal (Psychotic?) Behavior in Mice with Lysergic Acid Diethylamide, and Its Partial Prevention with Cholinergic Drugs and Serotonin Proc. Natl. Acad. Sci. U.S.A. 41, 338-344
31. Keller, D. L. and Umbreit, W. W. (1956) Permanent alteration of behavior in mice by chemical and psychological means Science 124, 723-724
32. Corne, S. J., Pickering, R. W., and Warner, B. T. (1963) A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine Br. J. Pharmacol. Chemother. 20, 106-120
33. Silva, M. T. and Calil, H. M. (1975) Screening hallucinogenic drugs: systematic study of three behavioral tests Psychopharmacologia 42, 163-171
34. Yamamoto, T. and Ueki, S. (1981) The role of central serotonergic mechanisms on head-twitch and backward locomotion induced by hallucinogenic drugs Pharmacol., Biochem. Behav. 14, 89-95 (Pubitemid 11143286)
35. Fantegrossi, W. E., Harrington, A. W., Eckler, J. R., Arshad, S., Rabin, R. A., Winter, J. C., Coop, A., Rice, K. C., and Woods, J. H. (2005) Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats Psychopharmacology (Berlin, Ger.) 181, 496-503 (Pubitemid 41480898)
36. Fantegrossi, W. E., Reissig, C. J., Katz, E. B., Yarosh, H. L., Rice, K. C., and Winter, J. C. (2008) Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents Pharmacol., Biochem. Behav. 88, 358-365 (Pubitemid 350123552)
37. Dixon, R. A., Kobilka, B. K., Strader, D. J., Benovic, J. L., Dohlman, H. G., Frielle, T., Bolanowski, M. A., Bennett, C. D., Rands, E., and Diehl, R. E. 1986, Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin Nature 321, 75-79 (Pubitemid 16080889)
38. Fargin, A., Raymond, J. R., Lohse, M. J., Kobilka, B. K., Caron, M. G., and Lefkowitz, R. J. (1988) The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor Nature 335, 358-360
39. Pritchett, D. B., Bach, A. W., Wozny, M., Taleb, O., Dal Toso, R., Shih, J. C., and Seeburg, P. H. (1988) Structure and functional expression of cloned rat serotonin 5HT-2 receptor EMBO J. 7, 4135-4140
40. Malick, J. B., Doren, E., and Barnett, A. (1977) Quipazine-induced head-twitch in mice Pharmacol., Biochem. Behav. 6, 325-329
41. Maj, J., Sowinska, H., Baran, L., Gancarczyk, L., and Rawlow, A. (1978) The central antiserotonergic action of mianserin Psychopharmacology (Berlin, Ger.) 59, 79-84 (Pubitemid 9013410)
42. McKenna, D. J. and Peroutka, S. J. (1989) Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo- phenylisopropylamine and 3H-ketanserin J. Neurosci. 9, 3482-3490 (Pubitemid 19260020)
43. Branchek, T., Adham, N., Macchi, M., Kao, H. T., and Hartig, P. R. (1990) [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor Mol. Pharmacol. 38, 604-609
44. Colpaert, F. C. and Janssen, P. A. (1983) The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist Neuropharmacology 22, 993-1000 (Pubitemid 13039234)
45. Schmid, C. L., Raehal, K. M., and Bohn, L. M. (2008) Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo Proc. Natl. Acad. Sci. U.S.A. 105, 1079-1084 (Pubitemid 351282084)
46. Willins, D. L. and Meltzer, H. Y. (1997) Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats J. Pharmacol. Exp. Ther. 282, 699-706 (Pubitemid 27340170)
47. Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., Whaley, R., Glennon, R. A., Hert, J., Thomas, K. L., Edwards, D. D., Shoichet, B. K., and Roth, B. L. (2009) Predicting new molecular targets for known drugs Nature 462, 175-181
48. Fantegrossi, W. E., Simoneau, J., Cohen, M. S., Zimmerman, S. M., Henson, C. M., Rice, K. C., and Woods, J. H. (2010) Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice J.Pharmacol. Exp. Ther. 335, 728-734
49. Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., and Humphrey, P. P. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin) Pharmacol. Rev. 46, 157-203 (Pubitemid 24185150)
50. Canal, C. E., Olaghere da Silva, U. B., Gresch, P. J., Watt, E. E., Sanders-Bush, E., and Airey, D. C. (2010) The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen Psychopharmacology (Berlin, Ger.) 209, 163-174
51. Darmani, N. a. and Pandya, D. K. (2000) Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice J. Neural Transm. 107, 931-945
52. Darmani, N. A., Janoyan, J. J., Kumar, N., and Crim, J. L. (2003) Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover Pharmacol., Biochem. Behav. 75, 777-787 (Pubitemid 37289462)
53. Matsumoto, K., Mizowaki, M., Thongpraditchote, S., Murakami, Y., and Watanabe, H. (1997) alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice Pharmacol., Biochem. Behav. 56, 417-422 (Pubitemid 27145820)
54. Mato, S., Aso, E., Castro, E., Martín, M., Valverde, O., Maldonado, R., and Pazos, A. (2007) CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors J. Neurochem. 103, 2111-2120 (Pubitemid 350126641)
55. Darmani, N. A. (2001) Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice Pharmacol., Biochem. Behav. 68, 311-317 (Pubitemid 32231193)
56. Moreno, J. L., Holloway, T., Albizu, L., Sealfon, S. C., and Gonzalez-Maeso, J. (2011) Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists Neurosci. Lett. 493, 76-79
57. Gonzalez-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., Lopez-Gimenez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., Gingrich, J. A., Filizola, M., Meana, J. J., and Sealfon, S. C. (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452, 93-97 (Pubitemid 351355090)
58. Fribourg, M., Moreno, J. L., Holloway, T., Provasi, D., Baki, L., Mahajan, R., Park, G., Adney, S. K., Hatcher, C., Eltit, J. M., Ruta, J. D., Albizu, L., Li, Z., Umali, A., Shim, J., Fabiato, A., Mackerell, A. D., Jr., Brezina, V., Sealfon, S. C., Filizola, M., Gonzalez-Maeso, J., and Logothetis, D. E. (2011) Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs Cell 147, 1011-1023
59. Fiorella, D., Rabin, R. A., and Winter, J. C. (1995) Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives Psychopharmacology (Berlin, Ger.) 121, 357-363
60. Fiorella, D., Rabin, R. A., and Winter, J. C. (1995) The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis Psychopharmacology (Berlin, Ger.) 121, 347-356
61. Winter, J. C., Fiorella, D. J., Timineri, D. M., Filipink, R. A., Helsley, S. E., and Rabin, R. A. (1999) Serotonergic receptor subtypes and hallucinogen-induced stimulus control Pharmacol., Biochem. Behav. 64, 283-293 (Pubitemid 29438613)
62. Winter, J. C., Kieres, A. K., Zimmerman, M. D., Reissig, C. J., Eckler, J. R., Ullrich, T., Rice, K. C., Rabin, R. A., and Richards, J. B. (2005) The stimulus properties of LSD in C57BL/6 mice Pharmacol., Biochem. Behav. 81, 830-837 (Pubitemid 41187816)
63. Smith, R. L., Barrett, R. J., and Sanders-Bush, E. (2003) Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(±)DOI] in C57BL/6J mice Psychopharmacology (Berlin, Ger.) 166, 61-68 (Pubitemid 36286721)
64. Doat, M. M., Rabin, R. A., and Winter, J. C. (2003) Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD Pharmacol., Biochem. Behav. 74, 713-721 (Pubitemid 36126550)
65. Gresch, P. J., Barrett, R. J., Sanders-Bush, E., and Smith, R. L. (2007) 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide J. Pharmacol. Exp. Ther. 320, 662-669 (Pubitemid 46147946)
66. Cameron, O. G. and Appel, J. B. (1973) A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats Psychopharmacologia. 33, 117-34
67. Appel, J. B., West, W. B., Rolandi, W. G., Alici, T., and Pechersky, K. (1999) Increasing the selectivity of drug discrimination procedures Pharmacol., Biochem. Behav. 64, 353-358 (Pubitemid 29438621)
68. Killinger, B. A., Peet, M. M., and Baker, L. E. (2010) Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats Pharmacol., Biochem. Behav. 96, 260-265
69. Winter, J. C. (1975) The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus Psychopharmacologia 44, 29-32
70. Crawley, J. N. (2007) Mouse behavioral assays relevant to the symptoms of autism Brain Pathol. 17, 448-459 (Pubitemid 47537604)
71. Commissaris, R., Lyness, W. H., Cordon, J. J., Moore, K. E., and Rech, R. H. (1980) The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats Pharmacol., Biochem. Behav. 13, 621-626 (Pubitemid 11253881)
72. Commissaris, R. L., Lyness, W. H., Moore, K. E., and Rech, R. H. (1980) Enhancement of the behavioral effects of 2,5-dimethoxy-4-methyl-amphetamine (DOM) by pretreatment with p-chlorophenylalanine Pharmacol., Biochem. Behav. 13, 605-608 (Pubitemid 10024784)
73. Mokler, D. J. and Rech, R. H. (1984) Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride Pharmacol., Biochem. Behav. 21, 281-287 (Pubitemid 14071932)
74. Commissaris, R. L., Lyness, W. H., Moore, K. E., and Rech, R. H. (1981) Central 5-hydroxytryptamine and the effects of hallucinogens and phenobarbital on operant responding in rats Pharmacol., Biochem. Behav. 14, 595-601 (Pubitemid 11123314)
75. Thompson, D. M., Winsauer, P. J., and Mastropaolo, J. (1987) Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys Pharmacol., Biochem. Behav. 26, 401-405 (Pubitemid 17038126)
76. Mokler, D. J., Stoudt, K. W., and Rech, R. H. (1985) The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs Pharmacol., Biochem. Behav. 22, 677-682 (Pubitemid 15120510)
77. Krebs-Thomson, K., Paulus, M. P., and Geyer, M. A. (1998) Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors Neuropsychopharmacology 18, 339-351 (Pubitemid 28140659)
78. Adams, L. M. and Geyer, M. A. (1985) Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide Pharmacol., Biochem. Behav. 23, 461-468 (Pubitemid 16256917)
79. Halberstadt, A. L., van der Heijden, I., Ruderman, M. A., Risbrough, V. B., Gingrich, J. A., Geyer, M. A., and Powell, S. B. (2009) 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice Neuropsychopharmacology 34, 1958-1967
80. Ninan, I. and Kulkarni, S. K. (1998) 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion Eur. J. Pharmacol. 358, 111-116 (Pubitemid 28458882)
81. O'Neill, M. F., Heron-Maxwell, C. L., and Shaw, G. (1999) 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB Pharmacol., Biochem. Behav. 63, 237-243 (Pubitemid 29234102)
82. Meltzer, H. and Massey, B. (2011) The role of serotonin receptors in the action of atypical antipsychotic drugs Curr. Opin. Pharmacol. 11, 59-67
83. Steed, E., Jones, C. A., and McCreary, A. C. (2011) Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study Behav. Brain Res. 220, 9-19
84. Williams, A. A., Ingram, W. M., Levine, S., Resnik, J., Kamel, C. M., Lish, J. R., Elizalde, D. I., Janowski, S. A., Shoker, J., Kozlenkov, A., Gonzalez-Maeso, J., and Gallitano, A. L. (XXXX) Reduced Levels of Serotonin 2A Receptors Underlie Resistance of Egr3-Deficient Mice to Locomotor Suppression by Clozapine Neuropsychopharmacology X, xxx-xxx
85. McOmish, C. E., Lira, A., Hanks, J. B., and Gingrich, J. A. (XXXX) Clozapine-Induced Locomotor Suppression is Mediated by 5-HT(2A) Receptors in the Forebrain Neuropsychopharmacology X, xxx-xxx
86. Powell, S. B. and Geyer, M. A. (2007) Overview of animal models of schizophrenia. Current Protocols in Neuroscience, Chapter 9, Unit 9 24.
87. Vollenweider, F. X., Csomor, P. A., Knappe, B., Geyer, M. A., and Quednow, B. B. (2007) The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval Neuropsychopharmacology 32, 1876-1887 (Pubitemid 47258517)
88. Ouagazzal, A., Grottick, A. J., Moreau, J., and Higgins, G. A. (2001) Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains Neuropsychopharmacology 25, 565-575 (Pubitemid 32830961)
89. Wischhof, L., Aho, H. E. A., and Koch, M. (2012) DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2/3 receptor stimulation Pharmacology, biochemistry, and behavior. 102, 6-12
90. Farid, M., Martinez, Z. A., Geyer, M. A., and Swerdlow, N. R. (2000) Regulation of sensorimotor gating of the startle reflex by serotonin 2A receptors. Ontogeny and strain differences Neuropsychopharmacology 23, 623-632
91. Brosda, J., Hayn, L., Klein, C., Koch, M., Meyer, C., Schallhorn, R., and Wegener, N. (2011) Pharmacological and parametrical investigation of prepulse inhibition of startle and prepulse elicited reactions in Wistar rats Pharmacol., Biochem. Behav. 99, 22-28
92. Halberstadt, A. L. and Geyer, M. A. (2010) LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor Psychopharmacology 208, 179-189
93. Schreiber, R., Melon, C., and De Vry, J. (1998) The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test Psychopharmacology 135, 383-391 (Pubitemid 28254845)
94. Nic Dhonnchadha, B. A., Bourin, M., and Hascoët, M. (2003) Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety Behav. Brain Res. 140, 203-214 (Pubitemid 36321745)
95. Winslow, J. T. and Insel, T. R. (1991) Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists Psychopharmacologia 105, 513-520
96. Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., and Jesse, R. (2011) Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects Psychopharmacology 218, 649-665
97. Hawkins, M. F., Uzelac, S. M., Baumeister, A. a., Hearn, J. K., Broussard, J. I., and Guillot, T. S. (2002) Behavioral responses to stress following central and peripheral injection of the 5-HT(2) agonist DOI Pharmacol., Biochem. Behav. 73, 537-544 (Pubitemid 34876704)
98. Magalhaes, A. C., Holmes, K. D., Dale, L. B., Comps-Agrar, L., Lee, D., Yadav, P. N., Drysdale, L., Poulter, M. O., Roth, B. L., Pin, J.-P., Anisman, H., and Ferguson, S. S. G. (2010) CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling Nature Neurosci. 13, 622-629
99. Weisstaub, N. V., Zhou, M., Lira, A., Lambe, E., Gonzalez-Maeso, J., Hornung, J. P., Sibille, E., Underwood, M., Itohara, S., Dauer, W. T., Ansorge, M. S., Morelli, E., Mann, J. J., Toth, M., Aghajanian, G., Sealfon, S. C., Hen, R., and Gingrich, J. A. (2006) Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice Science 313, 536-540 (Pubitemid 44148461)
100. de Oliveira Sergio, T., de Bortoli, V. C., and Zangrossi, H., Jr. (2011) Serotonin-2A receptor regulation of panic-like behavior in the rat dorsal periaqueductal gray matter: the role of GABA Psychopharmacology (Berlin, Ger.) 218, 725-732
101. Winstanley, C. A. (2011) The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders Br. J. Pharmacol. 164, 1301-1321
102. Hadamitzky, M. and Koch, M. (2009) Effects of acute intra-cerebral administration of the 5-HT(2A/C) receptor ligands DOI and ketanserin on impulse control in rats Behav. Brain Res. 204, 88-92
103. Wischhof, L., Hollensteiner, K. J., and Koch, M. (2011) Impulsive behaviour in rats induced by intracortical DOI infusions is antagonized by co-administration of an mGlu2/3 receptor agonist Behav. Pharmacol. 22, 805-813
104. Koskinen, T., Ruotsalainen, S., Puumala, T., Lappalainen, R., Koivisto, E., Männistö, P. T., and Sirviö, J. (2000) Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task Neuropharmacology 39, 471-481 (Pubitemid 30052936)
105. Matell, M. S. and Meck, W. H. (2004) Cortico-striatal circuits and interval timing: coincidence detection of oscillatory processes. Brain research Cognitive Brain Res. 21, 139-170 (Pubitemid 39298920)
106. Body, S., Cheung, T. H. C., Bezzina, G., Asgari, K., Fone, K. C. F., Glennon, J. C., Bradshaw, C. M., and Szabadi, E. (2006) Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors Psychopharmacology 189, 331-343 (Pubitemid 44772816)
107. Hampson, C. L., Body, S., den Boon, F. S., Cheung, T. H. C., Bezzina, G., Langley, R. W., Fone, K. C. F., Bradshaw, C. M., and Szabadi, E. (2010) Comparison of the effects of 2,5-dimethoxy-4-iodoamphetamine and D-amphetamine on the ability of rats to discriminate the durations and intensities of light stimuli Behav. Pharmacol. 21, 11-20
108. MacDonald, C. J. and Meck, W. H. (2005) Differential effects of clozapine and haloperidol on interval timing in the supraseconds range Psychopharmacologia 182, 232-244 (Pubitemid 41464616)
109. Miller, J. P., McAuley, J. D., and Pang, K. C. H. (2006) Effects of the NMDA receptor antagonist MK-801 on short-interval timing in rats Behav. Neurosci. 120, 162-172 (Pubitemid 43345113)
110. Cheng, R.-K., MacDonald, C. J., and Meck, W. H. (2006) Differential effects of cocaine and ketamine on time estimation: implications for neurobiological models of interval timing Pharmacol., Biochem. Behav. 85, 114-122 (Pubitemid 44772914)
111. Wittmann, M., Carter, O., Hasler, F., Cahn, B. R., Grimberg, U., Spring, P., Hell, D., Flohr, H., and Vollenweider, F. X. (2007) Effects of psilocybin on time perception and temporal control of behaviour in humans J. Psychopharmacol. (Oxford, U.K.) 21, 50-64 (Pubitemid 46012083)
112. Harvey, J. A. (1996) Serotonergic regulation of associative learning Behav. Brain Res. 73, 47-50 (Pubitemid 26008761)
113. Welsh, S. E., Romano, A. G., and Harvey, J. A. (1998) Effects of serotonin 5-HT(2A/2C) antagonists on associative learning in the rabbit Psychopharmacologia 137, 157-163 (Pubitemid 28227333)
114. Zhang, G., Asgeirsdóttir, H. N., Cohen, S. J., Munchow, A. H., Barrera, M. P., and Stackman, R. W. Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice. Neuropharmacology 2012, not supplied.
115. McLean, T. H., Parrish, J. C., Braden, M. R., Marona-Lewicka, D., Gallardo-Godoy, A., and Nichols, D. E. (2006) 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists J. Med. Chem. 49, 5794-5803 (Pubitemid 44423716)
116. Li, J.-x., Rice, K. C., and France, C. P. (2008) Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys J. Pharmacol. Exp. Ther. 324, 827-833 (Pubitemid 351185829)
117. White, F. J. and Appel, J. B. (1982) The role of dopamine and serotonin in the discriminative stimulus effects of lisuride J. Pharmacol Exp. Ther. 221, 421-427 (Pubitemid 12122960)
118. Rech, R. H. and Commissaris, R. L. (1982) Neurotransmitter basis of the behavioral effects of hallucinogens Neurosci. Biobehav. Rev. 6, 521-527 (Pubitemid 13170726)
119. Leriche, L., Schwartz, J.-C., and Sokoloff, P. (2003) The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade Neuropharmacology 45, 174-181 (Pubitemid 36782530)
120. Ma, J. and Leung, L. S. (2007) The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats Psychopharmacology 191, 961-974 (Pubitemid 46399137)
121. Morita, T., Hitomi, S., Saito, S., Fujita, T., Uchihashi, Y., and Kuribara, H. (1995) Repeated ketamine administration produces up-regulation of muscarinic acetylcholine receptors in the forebrain, and reduces behavioral sensitivity to scopolamine in mice Psychopharmacologia 117, 396-402
122. Ukai, M. and Kameyama, T. (1985) Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist Brain Res. 337, 352-356 (Pubitemid 15013795)
123. Sadalge, A., Coughlin, L., Fu, H., Wang, B., Valladares, O., Valentino, R., and Blendy, J. A. (2003) alpha 1d Adrenoceptor signaling is required for stimulus induced locomotor activity Mol. Psychiatry 8, 664-672 (Pubitemid 36976299)
124. Gould, T. D., O'Donnell, K. C., Picchini, A. M., and Manji, H. K. (2007) Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium Neuropsychopharmacology 32, 1321-1333 (Pubitemid 46788857)
125. Varty, G. B., Bakshi, V. P., and Geyer, M. A. (1999) M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats Neuropsychopharmacology 20, 311-321 (Pubitemid 29099762)
126. Singer, P. and Yee, B. K. (2012) Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice Pharmacol., Biochem. Behav. 101, 107-114
127. Bortolato, M., Aru, G. N., Frau, R., Orrù, M., Fà, M., Manunta, M., Puddu, M., Mereu, G., and Gessa, G. L. (2005) Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats Biol. Psychiatry 57, 1550-1558 (Pubitemid 40805385)
128. Tejeda, H. a., Chefer, V. I., Zapata, A., and Shippenberg, T. S. (2010) The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat Psychopharmacology 210, 231-240
129. Kinney, G. G., Burno, M., Campbell, U. C., Hernandez, L. M., Rodriguez, D., Bristow, L. J., and Conn, P. J. (2003) Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents J. Pharmacol. Exp. Ther. 306, 116-123 (Pubitemid 36734364)
130. Swerdlow, N. R., Stephany, N., Wasserman, L. C., Talledo, J., Shoemaker, J., and Auerbach, P. P. (2003) Amphetamine effects on prepulse inhibition across-species: replication and parametric extension Neuropsychopharmacology 28, 640-650
131. Gomes, K. S. and Nunes-De-Souza, R. L. (2009) Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice Prog. Neuro-Psychopharmacol. Biol. Psychiatry 33, 1261-1269
132. Zarrindast, M. R., Nasehi, M., Piri, M., and Heidari, N. (2011) Effects of cholinergic system of dorsal hippocampus of rats on MK-801 induced anxiolytic-like behavior Neurosci. Lett. 505, 65-70
133. Rodgers, R. J. and Cole, J. C. (1995) Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety Behav. Pharmacol. 6, 283-289
134. Braida, D., Capurro, V., Zani, A., Rubino, T., Viganò, D., Parolaro, D., and Sala, M. (2009) Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents Br. J. Pharmacol. 157, 844-853
135. Biała, G. and Kruk, M. (2007) Amphetamine-induced anxiety-related behavior in animal models Pharmacol. Rep. 59, 636-644 (Pubitemid 351586554)
136. Weiss, S. M., Wadsworth, G., Fletcher, A., and Dourish, C. T. (1998) Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety Neurosci. Biobehav. Rev. 23, 265-271 (Pubitemid 29011628)
137. Koskinen, T. and Sirviö, J. (2001) Studies on the involvement of the dopaminergic system in the 5-HT2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task Brain Res. Bull. 54, 65-75 (Pubitemid 32156917)
138. Koskinen, T., Ruotsalainen, S., and Sirviö, J. (2000) The 5-HT(2) receptor activation enhances impulsive responding without increasing motor activity in rats Pharmacol., Biochem. Behav. 66, 729-738 (Pubitemid 30639467)
139. Higgins, G. a., Enderlin, M., Haman, M., and Fletcher, P. J. (2003) The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism Psychopharmacology 170, 309-319 (Pubitemid 37491611)
140. Fletcher, P. J., Rizos, Z., Noble, K., and Higgins, G. a. (2011) Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade Neuropharmacology 61, 468-477
141. Mendez, I. A., Gilbert, R. J., Bizon, J. L., and Setlow, B. Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost-benefit decision making tasks in rats. Psychopharmacology 2012, not supplied.
142. Hayton, S. J., Maracle, A. C., and Olmstead, M. C. (2012) Opposite effects of amphetamine on impulsive action with fixed and variable delays to respond Neuropsychopharmacology 37, 651-659
143. Balci, F., Ludvig, E. A., Gibson, J. M., Allen, B. D., Frank, K. M., Kapustinski, B. J., Fedolak, T. E., and Brunner, D. (2008) Pharmacological manipulations of interval timing using the peak procedure in male C3H mice Psychopharmacologia 201, 67-80
144. Bolton, M. M., Heaney, C. F., Sabbagh, J. J., Murtishaw, A. S., Magcalas, C. M., and Kinney, J. W. (2012) Deficits in emotional learning and memory in an animal model of schizophrenia Behav. Brain Res. 233, 35-44
145. Rudy, J. W. (1996) Scopolamine administered before and after training impairs both contextual and auditory-cue fear conditioning Neurobiol. Learn. Mem. 65, 73-81 (Pubitemid 26112656)
146. Wood, S. C. and Anagnostaras, S. G. (2009) Memory and psychostimulants: modulation of Pavlovian fear conditioning by amphetamine in C57BL/6 mice Psychopharmacology 202, 197-206
147. Chan, W. Y. M. and McNally, G. P. (2009) Conditioned stimulus familiarity determines effects of MK-801 on fear extinction Behav. Neurosci. 123, 303-314
148. Santini, E., Sepulveda-Orengo, M., and Porter, J. T. (2012) Muscarinic receptors modulate the intrinsic excitability of infralimbic neurons and consolidation of fear extinction Neuropsychopharmacology 37, 2047-2056
149. Carmack, S. A., Wood, S. C., and Anagnostaras, S. G. (2010) Amphetamine and extinction of cued fear Neurosci. Lett. 468, 18-22